Login to Your Account



Bench Press


Monday, April 9, 2012
The 2009 RV144, or Thai AIDS vaccine trial, was the proverbial half-full glass. The vaccine did confer protection against AIDS; but at about 30 percent risk reduction, the vaccine was not effective enough to justify its further development.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription